Over the past several years, there has been a significant move towards the development of the mobile handset. For some companies, it has been a rewarding venture (Apple, Nokia) while for others it has been a struggle (Motorola, Siemens, Sanyo). A few that have been quietly changing the landscape of...
Just a quick question When did the journalists become the experts? I thought that the experts were the ones that were usually the information source for the television and print stories regarding the market. I know I have asked about this before, but this morning it really struck name when...
We have a new voice and comment system for the site. It is easy to use and will allow for you to leave a voice message or comment up to 2 minutes in length. If you would like to have a question answered on an upcoming podcast give it a...
It is amazing that no matter what, there are those that will find a way to cheat the system. In an apparent technology flaw, players could actually trade after the market closed, profiting on earnings and other news releases. The ability to do so was recently uncovered as a few...
Gamestop (GME) has a simple model: Sell new video games and then eventually buy them back from people who have become bored with them. The real power is in the second part of the strategy. GME buys a used game for, about $5-$10 and resell it for $20-$30. The people...
I have seen first hand the process of shorts unable to be delivered. Trading firms offer their clients shorts up to , say 10,000 shares on a stock for almost all stocks that trade. Then, when it actually comes to the part about delivery, it never happens. The requirements to...
The saga continues with DNDN. The stock is moving a bit higher. There are many people’s lives that may now be in further disarray as the long-awaited and deeply hoped-for FDA approval of the prostrate cancer treatment Provenge has been delayed. There is a rather large commotion concerning several inconsistencies...
Dendreon Corporation (DNDN) took a huge fall the past few days after the FDA released an update to their “Approvable Letter”, asking for additional information regarding the efficacy of Provenge. This drug is, as most would say; “potentially revolutionary because it aims to teach the body’s own immune system to...
